1-3 of 3
Ronald Anderson, MD
Close
Sort by
Journal Articles

Targeting Oncogenic Polyamines in Refractory Pediatric Leukemias Using the Anti-Protozoan Drug Α-Difluoromethylornithine (DFMO) in Combination with GC7 and Aurothioglucose

Bradley Hofmann, MSc, Sunand Kannappan, Gupta Mehul, Chunfen Zhang, MD, Susan Chi, MD, Derek Hanson, MD, Ronald Anderson, MD FRCPC, Aru Narendran, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2725.
https://doi.org/10.1182/blood-2018-99-117229
Published: 2018
Journal Articles

PedsQL ™ and EuroQol Most Responsive Measures To Change in Health-Related Quality of Life in Children with Hodgkin’s Disease.

Robert J. Klaassen, MD, Nicholas J. Barrowman, PhD, Ronald D. Barr, MD, Murray Krahn, MD, Joanna Hughes, BA, Paul Rogers, MD, Ronald Anderson, MD, Paul Grundy, MD, S. Kaiser Ali, MD, Rochelle Yanofsky, MD, Lawrence Jardin, MD, Oussama Abla, MD, Mariana Silva, MD, Anne-Sophie Carret, MD, Dorothy Barnard, MD, Mario Cappelli, PhD
Journal: Blood
Blood (2005) 106 (11): 1320.
https://doi.org/10.1182/blood.V106.11.1320.1320
Published: 2005
Journal Articles

Clinical Outcomes and the Impact of Anti-Thymocyte Globulin (ATG) and Chronic Graft Versus Host Disease (cGVHD) Following Pediatric Allogeneic Stem Cell Transplantation: A Comparison between Peripheral Blood and Bone Marrow as a Source of Stem Cells.

Parneet Cheema, Sunil Desai, MD, Ronald Anderson, MD, Max Coppes, MD, Victor A. Lewis, MD
Journal: Blood
Blood (2005) 106 (11): 1809.
https://doi.org/10.1182/blood.V106.11.1809.1809
Published: 2005